Financial Info

Financial Highlights  |  Ratios

Valuation P/E 97.30x   P/S 3.29x   P/B 6.50x   EPS 856.10	Financial Strength Quick Ratio (MRQ) 0.69x   Current Ratio (MRQ) 1.37x   Total Debt/Equity (MRQ) 0.66x   Total Debt/Assets (MRQ) 0.40x	Operating Ratios Assets Turnover (TTM) 1.22x   Inventory Turnover (TTM) 4.65x   Receivables Turnover (TTM) 10.10x
Profitability Gross Margin (TTM) 10.15%   Operating Margin (TTM) 3.75%   EBIT Margin (TTM) 4.39%   Profit Margin (TTM) 3.55%	Management Effectiveness ROA (TTM) 4.32%   ROE (TTM) 7.36%   ROIC (TTM) 5.27%	Growth Rate Diluted EPS Growth (TTM) -41.30%   Sales Growth (TTM) -2.01%   Profit Growth (TTM) -33.88%   Asset Growth (TTM) 18.54%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals...